Infiniwell Research Collaboration

Bridging Science and Practice for Better Outcomes

OvationLab and InfiniWell have established a strategic partnership to advance the clinical application of BPC-157, a peptide known for its regenerative properties. This collaboration focuses on enhancing the understanding and utilization of BPC-157 in functional and integrative medicine.

Clinical Research and Product Development

OvationLab conducted a landmark human study assessing the safety and efficacy of BPC-157 in adults with chronic pain. This research provided valuable insights into the peptide’s potential benefits for musculoskeletal and gastrointestinal health .

InfiniWell offers a range of BPC-157 formulations, including Rapid and Delayed Release capsules, designed to support joint, muscle, and gut health. These products incorporate Salcaprozate Sodium (SNAC) to enhance oral bioavailability, addressing the traditional challenges of peptide absorption.

Practitioner Education and Protocol Integration

The partnership emphasizes practitioner education through webinars, workshops, and the development of clinical protocols. By integrating BPC-157 into treatment plans, healthcare providers can offer targeted support for tissue repair, inflammation reduction, and gut-brain axis optimization.

Advancing Whole-Person Health

Together, OvationLab and InfiniWell contribute to the advancement of whole-person health by providing evidence-based solutions that align with the principles of functional and integrative medicine. Their collaborative efforts aim to enhance patient outcomes through innovative therapies and comprehensive practitioner support.

Learn more about the study results

Sign Up

Enter your email to sign up for our newsletter.

SOCIAL

Let's Talk

Feel free to reach out if you want to collaborate with us, or simply have a chat.

Connect